Company / Inventory
Emergent BioSolutions Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$343.4M
FY2025
5-year range
$311.7M / $350.8M
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
#25 of 105
Health Care
What the data says
Emergent BioSolutions Inc.'s inventory of $343M is higher than 76% of companies in the Health Care sector (FY2025). Inventory returned to growth in FY2025 after 3 years of decline, reaching $343M.
Based on SEC 10-K filings.
$343M in FY2025 with a 5-year CAGR of +2.3%. Top quartile in the Health Care sector.
Improved from $329M to $343M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -0.7%
- 5-Year CAGR
- +2.3%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 105This company $343.4M Sector average $885.3M
▼
-61.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.3%, indicating consistent growth.
- In FY2025, inventory increased 10.2% year-over-year.
- Ranks #25 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $343.4M | +10.2% |
| FY2024 | $311.7M | -5.2% |
| FY2023 | $328.9M | -6.2% |
| FY2022 | $350.7M | -0.0% |
| FY2021 | $350.8M | +14.3% |
| FY2020 | $307.0M | +38.0% |
| FY2019 | $222.5M | +8.1% |
| FY2018 | $205.8M | +44.1% |
| FY2017 | $142.8M | +93.0% |
| FY2016 | $74.0M | +21.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026